Advanced biomaterials and virtual reality for interventions in rare episodic cluster headache mimicking SUNCT syndrome: emerging directions in precision pain management.

Rare episodic cluster headache mimicking SUNCT syndrome presents a unique clinical challenge due to overlapping trigeminal autonomic features and limited therapeutic efficacy of conventional interventions. Recent innovations in advanced biomaterials, such as poly(L-lactic acid) and PVDF-based piezoelectric scaffolds integrated with decellularized extracellular matrix, offer biocompatible platforms for trigeminal nerve repair and inflammation modulation. Virtual reality (VR) technologies, through immersive pain-modulation environments, enhance neuroplasticity and empower patients in real-time symptom control. Artificial intelligence (AI) algorithms, incorporating multi-omic and wearable sensor data, enable personalized trigger profiling, predictive prevention, and early attack forecasting. CRISPR-based gene-editing strategies targeting pain-modulating genes, such as TACR1, have demonstrated potential in preclinical models for refractory headache management. Integrating these multidisciplinary innovations into clinical frameworks may pave the way for precision pain medicine, improved patient self-management, and enhanced long-term outcomes for those suffering from this debilitating headache disorder.